Challenges in respiratory vaccine development include immune response elicitation, personalized data, and alternative delivery methods like oral or intranasal routes to improve compliance. Federal ...
QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from concept to commercialization FORT LEE, N.J., Sept. 29, 2025 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback